Max Melmed
Professional summary
Max Melmed, who also goes by Max Allen Melmed, is a registered financial professional currently at AUGMENT CAPITAL, LLC located in New York, New York.
Max is registered as a RR (Registered Representative) and started their career in finance in 2012. Max has worked at 6 firms and has passed the Series 63, SIE, Series 7 and Series 24 exams.
Question & Answer
Aliases
Other business activities
CRS (Client Relationship Summary) - BD
Click below to view Max Melmed's CRS (Customer Relationship Summary).
Certified licenses
Experience
April 27, 2026 - Present
AUGMENT CAPITAL, LLC
Office #1: 33 Irving Place Suite 8124, New York, NY 10003December 23, 2024 - October 20, 2025
MMM SECURITIES LLC
October 27, 2020 - May 3, 2023
C2M SECURITIES, LLC
September 5, 2019 - October 22, 2020
IQ CAPITAL (USA) LLC
July 10, 2012 - May 10, 2019
SPEEDROUTE LLC
June 29, 2012 - May 10, 2019
TZERO SECURITIES, LLC
State Registrations and Notice Filings
Listed states reflect where the advisor is authorized to serve clients under state regulations.
Visual representation of state registrations
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/28/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
(4/27/2026)
Exams
FINRA
Current Firm
AUGMENT CAPITAL, LLC
CRD#: 322519 / SEC#: , 8-70989
Contact information
FINRA licenses (52 States and Territories)
Red Flags
Disclosures can be potential red flags, including customer disputes, regulatory fines, employer terminations, bankruptcies, judgments, liens, or certain criminal activities.
Check for any disclosures as part of your thorough research when choosing an advisor.